Skip to content
healthcare.dev

Palynziq

NDC 68135-673, pegvaliase-pqpz, injection, solution, from BioMarin Pharmaceutical Inc..

Product NDC
68135-673
Status
Listed
Labeler
BioMarin Pharmaceutical Inc.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761079
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68135-673 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PEGVALIASE20 mg/mL

Pharmacologic classes

Phenylalanine Ammonia-Lyase [CS]; Phenylalanine Metabolizing Enzyme [EPC]

Package NDCNDC-11Package
68135-673-40681350673401 SYRINGE in 1 CARTON (68135-673-40) / 1 mL in 1 SYRINGE (68135-673-39)
68135-673-456813506734510 SYRINGE in 1 CARTON (68135-673-45) / 1 mL in 1 SYRINGE (68135-673-39)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6dba844a-db02-44f8-8593-ce497ed9406c

Use it

Look up 68135-673 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68135-673 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68135-673. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.